HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Researchers unveil promising hepatitis C vaccine design | Scripps Research
![A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/5f70e2ed-642c-49e3-9230-5eba1fc35e56/gr1.gif "A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology")
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology
Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial | The BMJ
New affordable hepatitis C combination shows 97% cure rate | aidsmap
Hepatitis C Clinical Trial Cures 6-Year-Old Girl - Children's Health
Hepatitis C - Wikipedia
Viruses | Free Full-Text | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Hepatitis C Archives -
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of
Hepatitis C | HCV | MedlinePlus
Sofosbuvir/Velpatasvir for Patients With Chronic Genotype 3 HCV Infection With Compensated Cirrhosis: an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials
COVID-19: Fiocruz begins clinical trial with anti-hepatitis C drugs
Current and Future Therapies for Hepatitis C Virus Infection | NEJM
Current progress in development of hepatitis C virus vaccines | Nature Medicine
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial - The Lancet Gastroenterology & Hepatology
Epclusa Fact Sheet – Treatment Action Group
Trials of Hepatitis C drug to start on Covid-19 patients - The Indian Practitioner
%20Infections:%0A%0ARibavirin%20(RBV)%20for%20Hepatitis%20C.png?md=1 "Ribavirin (RBV) for Hepatitis C Clinical Trial 2023 | Power")
Ribavirin (RBV) for Hepatitis C Clinical Trial 2023 | Power
Hepatitis C and Clinical Trials - Consumer Health News | HealthDay
Gastroenterology Clinical Trials - Dallas, TX | GI Alliance
Clinical trials in HCV vaccine. All data below obtained from... | Download Table
Direct-acting agents to treat hepatitis C in phase 2 and 3 clinical... | Download Table
